143 related articles for article (PubMed ID: 8707961)
21. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
Hishinuma M; Ohashi KI; Yamauchi N; Kashima T; Uozaki H; Ota S; Kodama T; Aburatani H; Fukayama M
Histopathology; 2006 Nov; 49(5):479-86. PubMed ID: 17064293
[TBL] [Abstract][Full Text] [Related]
22. Hepatoid gastric adenocarcinoma. A histological and immunohistochemical study of a case.
Caruso RA
Eur J Basic Appl Histochem; 1991; 35(2):203-9. PubMed ID: 1722709
[TBL] [Abstract][Full Text] [Related]
23. [Immunocytohistochemical studies of AFP producing gastric cancer--cytomorphology and characteristics of AFP positive cells].
Kato T; Takahashi H; Ida Y; Watanabe Y; Sato Y; Takeda B
Rinsho Byori; 1993 Sep; 41(9):1024-30. PubMed ID: 7504755
[TBL] [Abstract][Full Text] [Related]
24. Alpha-fetoprotein-producing adenocarcinoma of the sigmoid colon with possible hepatoid differentiation.
Hocking GR; Shembrey M; Hay D; Ostör AG
Pathology; 1995 Jul; 27(3):277-9. PubMed ID: 8532396
[TBL] [Abstract][Full Text] [Related]
25. Alpha-fetoprotein-producing carcinoma of the renal pelvis exhibiting hepatoid and urothelial differentiation.
Samaratunga H; Samaratunga D; Dunglison N; Perry-Keene J; Nicklin J; Delahunt B
Anticancer Res; 2012 Nov; 32(11):4987-91. PubMed ID: 23155269
[TBL] [Abstract][Full Text] [Related]
26. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
[TBL] [Abstract][Full Text] [Related]
27. An analysis of clinicopathological features and prognosis by comparing hepatoid adenocarcinoma of the stomach with AFP-producing gastric cancer.
Liu X; Sheng W; Wang Y
J Surg Oncol; 2012 Sep; 106(3):299-303. PubMed ID: 22389029
[TBL] [Abstract][Full Text] [Related]
28. An alpha-fetoprotein-producing carcinoma of the rectum.
Yu YY; Ogino T; Okada S
Acta Pathol Jpn; 1992 Sep; 42(9):684-7. PubMed ID: 1282291
[TBL] [Abstract][Full Text] [Related]
29. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
30. Alpha fetoprotein producing gastric hepatoid adenocarcinoma.
Utkan G; Büyükçelik A; Ceyhan K; Ortabozkoyun L; Tek I; Yalçin B; Dinçol D
J Pak Med Assoc; 2006 Jun; 56(6):292-4. PubMed ID: 16827258
[TBL] [Abstract][Full Text] [Related]
31. Alpha-fetoprotein-producing hepatoid gastric adenocarcinoma in a child presenting with spontaneous gastric perforation.
Emir S; Karakurt N; Karakuş E; Şenel E; Kırsaçlıoğlu C; Demir HA; Orhan D
Turk J Pediatr; 2014; 56(1):88-91. PubMed ID: 24827954
[TBL] [Abstract][Full Text] [Related]
32. The immunohistochemical evaluation of estrogen receptor-alpha and progesterone receptors of normal, hyperplastic, and neoplastic endometrium in 88 pet rabbits.
Asakawa MG; Goldschmidt MH; Une Y; Nomura Y
Vet Pathol; 2008 Mar; 45(2):217-25. PubMed ID: 18424838
[TBL] [Abstract][Full Text] [Related]
33. Hepatoid differentiation in renal cell carcinoma: a rare histologic pattern with clinical significance.
Shim J; Go H; Lim YS; Moon KC; Ro JY; Cho YM
Ann Diagn Pathol; 2014 Dec; 18(6):363-8. PubMed ID: 25438926
[TBL] [Abstract][Full Text] [Related]
34. Hepatoid adenocarcinoma: a new clinicopathological entity and the hypotheses on carcinogenesis.
Kishimoto T; Nagai Y; Kato K; Ozaki D; Ishikura H
Med Electron Microsc; 2000; 33(2):57-63. PubMed ID: 11810459
[TBL] [Abstract][Full Text] [Related]
35. High-grade Endometrial Carcinoma With a Hepatoid Carcinoma-like Component.
Nishida K; Toji T; Taniguchi K; Shibata R; Ono S; Tanaka T; Yoshino T; Yanai H
Int J Gynecol Pathol; 2023 Jan; 42(1):63-67. PubMed ID: 35075047
[TBL] [Abstract][Full Text] [Related]
36. α-fetoprotein-producing endometrial adenocarcinoma without an obvious hepatoid component.
Kodama J; Seki N; Yanai H; Kusumoto T; Nakamura K; Hongo A; Hiramatsu Y
Oncol Lett; 2010 Mar; 1(2):243-245. PubMed ID: 22966288
[TBL] [Abstract][Full Text] [Related]
37. Primary hepatoid adenocarcinoma of the uterine cervix.
Kato K; Suzuka K; Osaki T; Itami M; Tanaka N
Int J Gynecol Cancer; 2007; 17(5):1150-4. PubMed ID: 17367323
[TBL] [Abstract][Full Text] [Related]
38. alpha-Fetoprotein-producing liver carcinomas of primary extrahepatic origin.
Wee A; Thamboo TP; Thomas A
Acta Cytol; 2003; 47(5):799-808. PubMed ID: 14526683
[TBL] [Abstract][Full Text] [Related]
39. Forkhead box protein A2, a pioneer factor for hepatogenesis, is involved in the expression of hepatic phenotype of alpha-fetoprotein-producing adenocarcinoma.
Yamamura N; Fugo K; Kishimoto T
Pathol Res Pract; 2017 Sep; 213(9):1082-1088. PubMed ID: 28778497
[TBL] [Abstract][Full Text] [Related]
40. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
